Top compounds associated with response to CABP4


Feature Type Standardized
Nominal ANOVA
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.092 0.01
mRNA SN-38 CTRPv2 pan-cancer AAC 0.094 0.01
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.085 0.01
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.09 0.01
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.094 0.01
mRNA YK 4-279 GDSC1000 pan-cancer AAC -0.092 0.01
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC 0.086 0.01
mRNA CID-5951923 CTRPv2 pan-cancer AAC 0.098 0.01
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.09 0.01
mRNA indisulam CTRPv2 pan-cancer AAC 0.081 0.01
Download CSV